key: cord-0913613-l5uy50lj
authors: Borgsteede, Sander D.; Geersing, Tjerk H.; Tempels‐Pavlica, Žana
title: Other excipients than PEG might cause serious hypersensitivity reactions in COVID‐19 vaccines
date: 2021-06-15
journal: Allergy
DOI: 10.1111/all.14774
sha: 3b9f1487cec726503df7b01a1f0c052240d1081d
doc_id: 913613
cord_uid: l5uy50lj

nan

To the Editor,

The availability of new vaccines against SARS-CoV-2 brings promising opportunities to prevent people from getting infected and developing COVID-19. As with other drugs, vaccines can cause adverse drug reactions (ADRs). Although generally the ADRs to vaccines are mild and serious reactions are very rare, 1 anaphylactic reactions were reported after administration of COVID-19 vaccines. 2 Cabanillas et al provide valuable background information that these anaphylactic reactions might be caused by polyethylene glycols (PEGs) that are part of lipid nanoparticles (LNPs) of mRNA-vaccines. 2 We agree that Table 1 lists the excipients of the vaccines currently used in the European c No hypersensitivity reactions have been reported, yet reactions to other phospholipids in pollen were described. 4 

Vaccine-associated hypersensitivity

Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?

Development of stable liquid formulations for adenovirus-based vaccines

Human CD1-restricted T cell recognition of lipids from pollens

Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging

Systemic allergy to EDTA in local anesthetic and radiocontrast media